Table 3 Comparison of serum and cerebrospinal fluid CXCL13 levels in NMO and MS patients with EDSS scores ≥ 3.5 and EDSS scores < 3.5.
Observation indicators | EDSS score ≥ 3.5 group | EDSS score<3.5 group | t | P |
---|---|---|---|---|
n | 43 | 41 | - | - |
Serum CXCL13 (pg/ml) | 85.12 ± 8.50 | 69.29 ± 7.78 | 8.895 | < 0.001 |
Cerebrospinal fluid CXCL13 (pg/ml) | 23.11 ± 8.09 | 13.16 ± 7.16 | 5.955 | < 0.001 |